Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Revenue for Y-mAbs Therapeutics (YMAB)
Revenue in 2023 (TTM): $84.81 M
According to Y-mAbs Therapeutics 's latest financial reports the company's current revenue (TTM) is $84.81 M. In 2022 the company made a revenue of $65.26 M an increase over the years 2021 revenue that were of $34.89 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Y-mAbs Therapeutics from 2018 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $84.81 M | 29.96% |
| 2022 | $65.26 M | 87.03% |
| 2021 | $34.89 M | 68.18% |
| 2020 | $20.75 M | |
| 2019 | N/A | |
| 2018 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |